Novateor Resear.

Why is Novateor Research Laboratories Ltd falling/rising?

As of 18-Jul, Novateor Research Laboratories Ltd's stock price is stable at 32.85, with a year-to-date increase of 36.88%. Despite no recent price movement, rising investor participation and strong performance relative to the Sensex suggest potential for future growth.

As of 18-Jul, Novateor Research Laboratories Ltd's stock price is currently stable at 32.85, showing no change (0.00%). Despite this stability, the stock has experienced a significant rise year-to-date, with an increase of 36.88%, contrasting sharply with the Sensex, which has fallen by 8.30% during the same period. <BR><BR>In the short term, the stock has not seen any price movement over the past week or month, both recording a change of 0.00%. However, it has outperformed its sector by 2.46% today, indicating some positive momentum relative to its peers. <BR><BR>Investor participation appears to be rising, as evidenced by a notable increase in delivery volume, which rose by 900% on 07 May compared to the 5-day average. This suggests growing interest among investors, potentially supporting future price movements. <BR><BR>While the stock is currently trading above its 5-day, 20-day, and 200-day moving averages, it remains below its 50-day and 100-day moving averages, indicating mixed signals regarding its short-term performance. Additionally, the stock's liquidity is adequate for trading, which may facilitate further investment activity. <BR><BR>Overall, while the stock price is not currently rising or falling, the underlying factors suggest a potential for future growth, driven by increased investor participation and a strong year-to-date performance.

Which are the latest news on Novateor Resear.?

What does Novateor Resear. do?

Novateor Research Laboratories Ltd is a micro-cap company in the FMCG industry, incorporated in 2011 and converted to a public company in 2019. As of March 2020, it reported net sales and net profit of 0 Cr, with a market cap of INR 20 Cr.

Overview: <BR>Novateor Research Laboratories Ltd operates in the Fast-Moving Consumer Goods (FMCG) industry and is categorized as a micro-cap company.<BR><BR>History: <BR>The company was originally incorporated as Novateor Research Laboratories Private Limited in 2011 and later converted to a Public Limited Company, changing its name to Novateor Research Laboratories Limited on April 22, 2019. The latest quarterly results reported net sales and net profit of 0 Cr for March 2020.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Cr (Quarterly Results - Mar 2020) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2020) <BR>Market-cap value: INR 20 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 249.00 <BR>Industry P/E: 81 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.08 <BR>Return on Equity: 1.00% <BR>Price to Book: 2.47 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

How big is Novateor Resear.?

As of 10th June, Novateor Research Laboratories Ltd has a market capitalization of 20.00 Cr, with recent net sales of 0.13 Cr and a net profit loss of 0.02 Cr. Shareholder's funds are 10.54 Cr, and total assets amount to 12.61 Cr as of March 2025.

As of 10th June, <BR><BR>Market Cap: Novateor Research Laboratories Ltd has a market capitalization of 20.00 Cr, categorizing it as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest quarter ending March 2020, the company reported Net Sales of 0.13 Cr and a Net Profit loss of 0.02 Cr.<BR><BR>Balance Sheet Snapshot: The latest annual reporting period is March 2025, with Shareholder's Funds amounting to 10.54 Cr and Total Assets of 12.61 Cr.

Who are in the management team of Novateor Resear.?

The management team of Novateor Resear includes Navdeep Subhashbhai Mehta (Managing Director & CFO), Tejal Navdeep Mehta (Whole-time Director), and independent directors Anand Rajendra Shah, Chintan Pankaj Shah, and Sindhav Vipulbhai, along with non-executive director Jitin Jaysukh Doshi.

The management team of Novateor Resear includes the following individuals:<BR><BR>1. **Navdeep Subhashbhai Mehta** - Managing Director & CFO<BR>2. **Tejal Navdeep Mehta** - Whole-time Director<BR>3. **Anand Rajendra Shah** - Independent Director<BR>4. **Chintan Pankaj Shah** - Independent Director<BR>5. **Sindhav Vipulbhai** - Independent Director<BR>6. **Jitin Jaysukh Doshi** - Non Executive Director<BR><BR>If you need more specific information about their roles or contributions, feel free to ask!

Who are the peers of the Novateor Resear.?

Novateor Resear.'s peers include Sonalis Consumer, Jay Kailash, Lake Shore, Indong Tea Co, Shivamshree Busi, BKV Industries, Paramount Cosmet, Tapi Fruit, and Walpar Nutrition. Novateor Resear. has Below Average management and capital risk, with a 1-year return of -42.87%, lower than its peers.

Peers: The peers of Novateor Resear. are Sonalis Consumer, Jay Kailash, Lake Shore, Indong Tea Co, Shivamshree Busi, BKV Industries, Paramount Cosmet, Tapi Fruit, and Walpar Nutrition.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sonalis Consumer and Walpar Nutrition, while Below Average management risk is found at Jay Kailash, Novateor Resear., Indong Tea Co, Shivamshree Busi, Paramount Cosmet, and Tapi Fruit, and the rest. Average growth is noted at Novateor Resear. and Shivamshree Busi, while Below Average growth is seen at Jay Kailash, Indong Tea Co, Paramount Cosmet, and Tapi Fruit, and the rest. Good capital structure is present at Sonalis Consumer and Walpar Nutrition, while Below Average capital structure is found at Jay Kailash, Novateor Resear., Indong Tea Co, Shivamshree Busi, Paramount Cosmet, and Tapi Fruit, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Jay Kailash at -33.11%, while the peer with the lowest is Sonalis Consumer at -28.39%, and Novateor Resear.'s 1-year return is -42.87%, which is lower than both. Additionally, Indong Tea Co, Shivamshree Busi, Paramount Cosmet, and Tapi Fruit all have negative six-month returns.

When is the next results date for Novateor Research Laboratories Ltd?

Novateor Research Laboratories Ltd will announce its results on 30 May 2026.

Novateor Research Laboratories Ltd is scheduled to declare its results on 30 May 2026.

Who are the top shareholders of the Novateor Resear.?

The top shareholders of Novateor Resear include Navdeep Subhashbhai Mehta with 29.56%, individual investors with 26.45%, and public shareholder Jitin Jaysukhlal Doshi at 3.85%. There are currently no mutual funds or foreign institutional investors holding shares in the company.

The top shareholders of Novateor Resear include the promoters, with Navdeep Subhashbhai Mehta holding the largest stake at 29.56%. Individual investors collectively own 26.45% of the company. The highest public shareholder is Jitin Jaysukhlal Doshi, who holds 3.85%. Notably, there are no mutual funds or foreign institutional investors currently holding shares in the company.

Is Novateor Resear. overvalued or undervalued?

As of May 19, 2025, Novateor Research is rated as risky and overvalued, with a PE Ratio of 27.80, negative ROCE of -4.59%, and ROE of 0.38%, despite outperforming the Sensex with an 18.9% return over the past year.

As of 19 May 2025, the valuation grade for Novateor Research has moved from does not qualify to risky, indicating a significant shift in its perceived investment quality. The company is currently deemed overvalued. Key ratios include a PE Ratio of 27.80, a Price to Book Value of 3.51, and an EV to Sales ratio of 23.81, which suggest that the stock is priced high relative to its earnings and book value.<BR><BR>In comparison to its peers, Novateor Research's PE Ratio stands in stark contrast to Max Healthcare Institute Ltd., which has a PE of 100.29, and Apollo Hospitals Enterprise Ltd., with a PE of 69.03, both categorized as very expensive. This highlights the relative valuation concerns for Novateor Research, especially given its negative ROCE of -4.59% and ROE of 0.38%. While Novateor has outperformed the Sensex over the past year with a return of 18.9% compared to the Sensex's 7.55%, the underlying financial metrics suggest caution for potential investors.

What is the technical trend for Novateor Resear.?

As of May 15, 2025, Novateor Research's technical trend is neutral, with no clear bullish or bearish indicators, as the stock price remains unchanged at 57.50 despite strong long-term performance relative to the Sensex.

As of 15 May 2025, the technical trend for Novateor Resear has changed from mildly bearish to does not qualify. Given the lack of specific technical indicators such as MACD, RSI, or moving averages, and the current price remaining unchanged at 57.50, there is insufficient data to form a definitive bullish or bearish stance. The stock's performance relative to the Sensex shows strong returns over the longer term, but current technical analysis does not provide a clear direction.

Has Novateor Resear. declared dividend?

No Dividend History Available